Sam Galvagno- Osmotherapy: Agents to know for your next "Brain Code"

Today we are once again excited to have Dr./LtCol/All-around critical care guru Sam Galvagno. In addition to publishing in multiple major journals, defending the country, maintaining FOUR board certifications, AND maintaining a PhD in Clinical Research; Dr. Galvagno somehow finds time away from his job as Associate Director of the University of Maryland SICU to do what he does best: share his advanced knowledge of critical care. It is an honor and a privilege to share with you a lecture topic that Dr. Galvagno has spent many years researching: Osmotherapy. I assure you, no matter what your level of exposure is to this topic I GUARANTEE you will take away a TON of new clinical pearls!!


Key points

  • Pearl #1: Egress of water = Loss of volume in the cranial vault
    • Monroe-Kelley Doctrine!
    • This is a BRIDGE to definitive therapy!
  • Pearl #2: Water movement in the brain is NOT PASSIVE
    • Need to physically alter the osmotic equilibrium with:
      • A non-toxic, inert, object with COMPLETE exclusion from the brain
  • Pearl #3: A 1.6% reduction in brain volume = 90 ml of brain tissue saved!! 
    • An Osm of 300-320 will:
      • Allow active egress of water from the brain tissue → decreased intracranial volume
      • Improve elasticity of the cranial vault
  • Pearl #4: There is NO JUSTIFICATION in withholding an osmolar agent due to lack of central access
    • NO study shows significant harm is caused by using PIV
  • Pearl #5: Osmotherapy agent effects extend beyond simply osmotic action:

Osmotherapy actions

Mannitol

  • 1100 mOsm/L
  • Dose: 0.25-1.5g/kg
  • Takes 15-30 minutes for full effect, i.e.: takes time to lower ICP
    • Lasts 2-4 hours
  • Effects:
    • Concentration gradient → egress of intracranial fluid
    • Volume expansion (detrimental in CHF) → increased CO → improved CPP
    • Vasoconstriction + decreased viscosity → improved CBF
    • Proximal tubule diuretic (detrimental in AKI/CKD)
    • Free radical scavenger
  • Goal:
    • DO NOT worry about a desired serum osm goal (i.e. <320…)
    • Calculate Serum Osm Gap 
      • Renal failure rare with Osm Gap < 55!!
  • Adverse effects:
    • #1 side effect- diuresis → hypovolemia and hypotension
    • Pulmonary edema, metabolic acidosis, hemolysis, AKI, hyperkalemia

Hypertonic Saline

  • 3% 1027 mOsm/L, 5% 1711 mOsm/L, 23.4% 8000 mOsm/L
  • Dose: 1-2 cc/kg/hr 3% or 4-6cc/kg/hr 2% (Ideal Body Weight)
    • Lasts 48 to 72 hours
  • Rise in Sodium can be augmented with simultaneous use of loop diuretic
  • CAUTION:
    • Chloride load leads to SEVERE hyperchloremic metabolic acidosis
    • Sudden rise in sodium can lead to Central Pontine Myelinolysis (but…. only one documented case)
  • Effects:

HSS benefits Galvagno

  • Goal:
    • Na level 145-160 (i.e. Osm 300-320)
  • Adverse effects:
    • In addition to acidosis and CPM, a rapid ICP drop can tear bridging veins and lead to a SDH

Hypertonic Saline vs. Mannitol

  • No study has ever shown a remarkable difference (yet….)

Leave a Comment

Scroll to Top
Verified by ExactMetrics